Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jonas Scheid

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
Cancers|May 14, 2022
HLA-DR Presentation of the Tumor Antigen MSLN Associates with Clinical Outcome of Ovarian Cancer PatientsChristian M Tegeler, Jonas Scheid, Hans-Georg Rammensee, et al.
Genome Biology|September 22, 2025
MHCquant2 refines immunopeptidomics tumor antigen discoveryJonas Scheid, Steffen Lemke, Naomi Hoenisch-Gravel, et al.
Journal for Immunotherapy of Cancer|April 15, 2025
PCI-DB: a novel primary tissue immunopeptidome database to guide next-generation peptide-based immunotherapy developmentSteffen Lemke, Marissa L Dubbelaar, Patrick Zimmermann, et al.
Nature Communications|October 23, 2023
DNMT and HDAC inhibition induces immunogenic neoantigens from human endogenous retroviral element-derived transcriptsAshish Goyal, Jens Bauer, Joschka Hey, et al.
Journal of Proteomics|July 4, 2024
Proceedings of the EuBIC-MS developers meeting 2023Pedro Beltrao, Tim Van Den Bossche, Ralf Gabriels, et al.
Journal of Proteome Research|February 7, 2025
TIMS<sup>2</sup>Rescore: A Data Dependent Acquisition-Parallel Accumulation and Serial Fragmentation-Optimized Data-Driven Rescoring Pipeline Based on MS<sup>2</sup>RescoreArthur Declercq, Robbe Devreese, Jonas Scheid, et al.
Nature Communications|November 18, 2023
TOF<sub>IMS</sub> mass spectrometry-based immunopeptidomics refines tumor antigen identificationNaomi Hoenisch Gravel, Annika Nelde, Jens Bauer, et al.
Nature Communications|October 27, 2022
The oncogenic fusion protein DNAJB1-PRKACA can be specifically targeted by peptide-based immunotherapy in fibrolamellar hepatocellular carcinomaJens Bauer, Natalie Köhler, Yacine Maringer, et al.
Cancer Research|October 3, 2025
FLT3-ITD Induces CMTM6 and Enhances Immune Escape in Acute Myeloid LeukemiaMelissa Zwick, Bastian Zinkel, Corinna Spohr, et al.
Nature Communications|February 5, 2025
Mapping naturally presented T cell antigens in medulloblastoma based on integrative multi-omicsJulia Velz, Lena K Freudenmann, Gioele Medici, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Cancers|May 14, 2022
HLA-DR Presentation of the Tumor Antigen MSLN Associates with Clinical Outcome of Ovarian Cancer PatientsChristian M Tegeler, Jonas Scheid, Hans-Georg Rammensee, et al.
Genome Biology|September 22, 2025
MHCquant2 refines immunopeptidomics tumor antigen discoveryJonas Scheid, Steffen Lemke, Naomi Hoenisch-Gravel, et al.
Journal for Immunotherapy of Cancer|April 15, 2025
PCI-DB: a novel primary tissue immunopeptidome database to guide next-generation peptide-based immunotherapy developmentSteffen Lemke, Marissa L Dubbelaar, Patrick Zimmermann, et al.
Nature Communications|October 23, 2023
DNMT and HDAC inhibition induces immunogenic neoantigens from human endogenous retroviral element-derived transcriptsAshish Goyal, Jens Bauer, Joschka Hey, et al.
Journal of Proteomics|July 4, 2024
Proceedings of the EuBIC-MS developers meeting 2023Pedro Beltrao, Tim Van Den Bossche, Ralf Gabriels, et al.
Journal of Proteome Research|February 7, 2025
TIMS<sup>2</sup>Rescore: A Data Dependent Acquisition-Parallel Accumulation and Serial Fragmentation-Optimized Data-Driven Rescoring Pipeline Based on MS<sup>2</sup>RescoreArthur Declercq, Robbe Devreese, Jonas Scheid, et al.
Nature Communications|November 18, 2023
TOF<sub>IMS</sub> mass spectrometry-based immunopeptidomics refines tumor antigen identificationNaomi Hoenisch Gravel, Annika Nelde, Jens Bauer, et al.
Nature Communications|October 27, 2022
The oncogenic fusion protein DNAJB1-PRKACA can be specifically targeted by peptide-based immunotherapy in fibrolamellar hepatocellular carcinomaJens Bauer, Natalie Köhler, Yacine Maringer, et al.
Cancer Research|October 3, 2025
FLT3-ITD Induces CMTM6 and Enhances Immune Escape in Acute Myeloid LeukemiaMelissa Zwick, Bastian Zinkel, Corinna Spohr, et al.
Nature Communications|February 5, 2025
Mapping naturally presented T cell antigens in medulloblastoma based on integrative multi-omicsJulia Velz, Lena K Freudenmann, Gioele Medici, et al.
Pageof 2